法国头颈部黏膜黑色素瘤的肿瘤学结局、预后因素分析与治疗算法评估
基于法国国家级罕见头颈癌专家网络2000—2017年前瞻性数据库,纳入314例头颈部黏膜黑色素瘤患者,分析临床特征、治疗模式、结局及预后因素。手术组5年总生存率和无进展生存率分别为49.4%和24.7%,无法手术者无长期生存;多因素分析显示UICC分期和肿瘤部位与PFS和OS相关,术后放疗改善小T3期鼻腔鼻窦及口腔黏膜黑色素瘤的PFS但未改善OS。
要点
- 手术组5年OS为49.4%、PFS为24.7%,无法手术者无长期生存。
- 即使手术切缘阴性,中位PFS仅22个月,远处转移导致预后差。
- 术后放疗改善小T3期SNMM和OCMM的PFS,但未改善OS。
核心结论
- 即使早期头颈部黏膜黑色素瘤,尽管手术切缘阴性,因远处转移仍导致肿瘤学结局差。
- 淋巴结转移对预后无显著影响,提示颈部淋巴结管理可考虑降阶梯治疗。
- 术后放疗可能有助于局部控制。
研究设计与样本
- 基于法国罕见头颈癌专家网络前瞻性国家数据库2000—2017年纳入的314例头颈部黏膜黑色素瘤患者。
- 分析临床特征、治疗方式、结局及预后因素。
主要发现
- 手术组5年总生存率为49.4%,5年无进展生存率为24.7%。
- 无法手术者未观察到长期生存者。
- 即使手术后复发率高,中位无进展生存期为22个月。
- 多因素分析中UICC分期和肿瘤部位与PFS和OS相关。
- 术后放疗改善小T3期鼻腔鼻窦黏膜黑色素瘤和口腔黏膜黑色素瘤患者的PFS,但未改善OS。
关键数值与推荐
- 手术组5年OS为49.4%,5年PFS为24.7%。
- 手术后中位PFS为22个月。
- 口腔黏膜黑色素瘤淋巴结受累较鼻腔鼻窦黏膜黑色素瘤更常见(p < 10-4)。
- 术后放疗改善小T3期SNMM和OCMM的PFS,但未改善OS。
临床怎么用
- 对于可手术的头颈部黏膜黑色素瘤,手术仍是主要治疗方式,但需警惕高复发和远处转移风险。
- 术后放疗可考虑用于小T3期鼻腔鼻窦和口腔黏膜黑色素瘤以改善局部控制。
- 颈部淋巴结管理可考虑降阶梯治疗,因淋巴结转移对预后无显著影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Head and neck mucosal melanoma (HNMM) is aggressive and rare, with a poor prognosis because of its high metastatic potential. The two main subtypes are sinonasal (sinonasal mucosal melanoma [SNMM]) and oral cavity (oral cavity mucosal melanoma [OCMM]). Consensual therapeutic guidelines considering the primary tumour site and tumour-node-metastasis (TNM) stage are not well established. MATERIAL & METHODS: Patients with HNMM from the prospective national French Rare Head and Neck Cancer Expert Network database between 2000 and 2017 were included. Clinical characteristics, treatment modalities, outcomes and prognostic factors were analysed. RESULTS: In total, 314 patients were included. The 5-year overall survival (OS) and progression-free survival (PFS) rates were 49.4% and 24.7%, respectively, in the surgery group; no long-term survivors were observed when surgery was not feasible. Moreover, even after surgery, a high recurrence rate was reported with a median PFS of 22 months. In multivariate analysis, Union for International Cancer Control (UICC) stage and tumour site correlated with PFS and OS. Postoperative radiotherapy (PORT) improved the PFS but not OS in patients with small (T3) SNMM and OCMM tumours. Nodal involvement was more frequent in patients with OCMM (p < 10-4), although, as in SNMM, it was not a significant prognostic predictor. CONCLUSION: Even early HNMM was associated with poor oncologic outcomes due to distant metastases despite surgical resection with clear margins. Lymph node metastases had no impact on the prognosis, suggesting treatment de-escalation in cervical node management. PORT might be useful for local control.
引用
- Moya-Plana A, Aupérin A, Obongo R, et al. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France. Eur J Cancer. 2019. PMID: 31670075. doi:10.1016/j.ejca.2019.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。